Hamburg, 15 October 2021 How herpes seizes proteins’ means of production The Graham and Crump groups at the University of Cambridge and the Svergun Group at EMBL Hamburg have discovered a mechanism by which the herpes simplex virus takes control of the molecular machinery of human cells. Their work reveals how a dedicated viral protein hijacks key host proteins, forcing the host cell to produce and release copies of the virus.
Heidelberg, 13 October 2021 Tackling the collateral damage from antibiotics Antibiotics help us to get rid of bacterial infections – but they can also harm the helpful microbes residing in our guts. Researchers from the Typas group at EMBL Heidelberg and collaborators have analysed the effects of 144 antibiotics on the wellbeing of our most common gut microbes. The study significantly improves our understanding of antibiotics’ side effects and suggests a new approach to mitigating the adverse effects of antibiotics therapy on gut bacteria.
General, 8 October 2021 EMBL and Ifremer cooperate to advance ocean sciences The two organisations have signed a memorandum of understanding to support scientific cooperation in the exploration of coastal and oceanic ecosystems, the study of marine biodiversity, and the understanding of host-pathogen-environment interactions in the marine environment.
Barcelona, Grenoble, Hamburg, Heidelberg, Hinxton, Rome, 4 October 2021 EMBL strengthens links with Estonia Since June 2019, Estonia has been a prospect member state of the European Molecular Biology Laboratory (EMBL). A memorandum of understanding (MoU) has now been signed between EMBL and the University of Tartu, a leading centre of research and training. The MoU aims to strengthen cooperation between EMBL and the life science research community in Estonia, building on the very successful links in the context of the prospect membership.
Heidelberg, 28 September 2021 Celebrating Hungary-EMBL collaborations for life sciences research EMBL will strengthen already close collaborations with Hungarian research institutes to jointly address urgent biological and environmental challenges, including antimicrobial resistance and infectious diseases.